Baker Avenue Asset Management, LP
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1432529
SAN FRANCISCO, CA
Position in BMRN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$321,597
+$321,244 QoQ
Shares Held
5,693
+142225.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
3 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $4,381,815 across 10 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
26,219 | $1,166,483 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
13,279 | $771,908 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
2,447 | $589,653 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
931 | $580,515 | |
| 5 | RPRX |
Royalty Pharma plc
|
6,991 | $391,985 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
653 | $324,364 | |
| 7 | INCY |
Incyte Corp
|
2,148 | $243,497 | |
| 8 | EXEL |
Exelixis, Inc.
|
3,885 | $211,382 |
All Filings in BMRN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,597 | 5,693 | Shares | Sole | 2026-05-12 | |
| 2023-09-30 | $353 | 4 | Shares | Sole | 2023-11-15 | |
| 2022-12-31 | $2,173 | 21 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||